New ETF Recommendations
The AlphaProfit ETF style rotation model portfolio will be reconstituted with new recommendations on Monday, November 20. Learn more about AlphaProfit's Free and Premium Service investment newsletters.
"In the investing blog, I seek to help you take sound investment decisions free from emotion by sharing my objective insights on markets, sectors, and companies."
The first half of 2009 has been tough on most momentum-based strategies. After declining 11.0% in the first quarter, the broad market turned around and staged a roaring rally. The S&P 500 is now up 15.7% for the second quarter. The snap in performance between the first and second quarters is even more striking at a sector level.… Read More »
Although the S&P 500 has advanced 32% since the March 9 market bottom, the rally has been quite selective from a sector perspective. Groups decimated during the recent bear market have rallied the most. Financial shares are up big after losing 81% from September 30, 2007. With investors demonstrating healthy risk appetite, defensive sectors have generally lagged. Utilities… Read More »
Mutual fund titans Vanguard and Fidelity are taking different approaches to compete against sector ETFs. The allure of low expense ratios, better transparency, and ready liquidity has made exchange-traded funds (ETFs) a popular investment vehicle. The robust returns earned off-late by energy and other commodity ETFs have resulted in money gravitating towards such ETFs. The Energy Select Sector… Read More »
This article originally appeared in The Motley Fool on December 14, 2005. Technology companies are generally underappreciated as energy conservation plays. By casting a wider net, investors can find appealing situations in the technology space that stand to prosper from the growing emphasis on energy conservation. Investors typically see oil-related stocks — such as Exxon Mobil (NYSE: XOM)… Read More »
Biotechnology, which has been on a roll, declined after the much-anticipated American Society of Clinical Oncologists meeting in early June in New Orleans, where cancer specialists deliberated on the merits of new treatments. The two extant ETFs which focus on this industry are iShares Nasdaq Biotechnology (AMEX:IBB) and Biotech HOLDRs (AMEX:BBH). Before deciding to dump or load up… Read More »
Investing in biotech stocks has never been for the faint-hearted as many biotech companies have high cash burn rates. The biotech industry however has a few things going for it. Read on to learn more about investment opportunities in this industry. Shares of biotechnology companies have declined, after the much anticipated American Society of Clinical Oncologists meeting in… Read More »
The favorable dynamics for the Biotechnology industry is attracting investor attention. On the heels of recent gains, there are reasons to be optimistic on continued out-performance. An efficient Food and Drug Administration, progress on extension of new products, trouble in ‘major pharma’ land and reasonable valuation create a favorable milieu for investing in the biotechnology sector. These conditions… Read More »
THE GOOD NEWS JUST BEGINS!